Search

everythinglearnresearchcommunity

for

Search:↓

Deuruxolitinib improves anxiety and depression in severe alopecia areata patients.

Abrocitinib helped a 14-year-old girl with severe alopecia areata regrow her hair significantly.

Deuruxolitinib significantly improves hair satisfaction in severe alopecia areata patients.

Ritlecitinib effectively improves hair regrowth and physician satisfaction in severe alopecia areata over time.

A PIK3CA mutation in Schwann cells causes severe nerve damage and increased glycolysis, but early treatment can help.

Unique microRNA patterns can help diagnose and treat severe alopecia areata.

JAK inhibitors like tofacitinib are effective and safer for severe alopecia areata than glucocorticosteroids.

Ivarmacitinib effectively regrows hair in severe alopecia areata.

Early diagnosis and treatment of NCCAH can improve symptoms and fertility.

Baricitinib helps regrow hair in severe alopecia areata and is safe, but more research is needed.

People with androgenetic alopecia had milder COVID-19 symptoms during the Omicron wave in China.

Combining platelet-rich plasma and minoxidil can effectively regrow hair in severe alopecia areata cases.

Combining methotrexate and corticosteroids can effectively regrow hair in severe alopecia areata.

Clomiphene testing can help find ovarian causes of high testosterone in postmenopausal women.

Baricitinib effectively reduces hair loss in severe alopecia areata with mild side effects.

Continued baricitinib treatment leads to significant scalp hair regrowth in severe alopecia areata patients.

People with hair loss may have worse urinary symptoms due to an enlarged prostate.

COVID-19 can cause various skin issues, with some linked to how severe the illness is.

Continuous baricitinib is needed to keep hair regrowth in severe alopecia areata.

Rezpegaldesleukin shows promise for treating severe alopecia areata.

Iron deficiency can cause psychiatric symptoms that improve with proper treatment.

Stem cell therapies, especially adipose-derived ones, show promise for treating severe COVID-19 and related conditions.

Hormonal changes and social stress may link lupus and eating disorders in teens.

Baricitinib therapy helped many patients with severe alopecia regrow hair after 52 weeks.

Pilonidal sinus disease is linked to more severe hidradenitis suppurativa.

Baricitinib effectively regrows hair in most people with severe alopecia, especially those with patchy hair loss, but hair may fall out again if treatment stops.

Baricitinib shows promise in treating severe hair loss.

The trial will test if proxalutamide is safe and effective in reducing death in severe COVID-19 patients.

The treatment helped a transgender woman stop drinking, improved her mental health, and reduced her gender dysphoria.